April 19, 2024 Bitcoin Halving: Catalyst for New Price Heights?
April 18, 2024 EU Moves Toward Single Capital Market Union
April 17, 2024 Bitcoin Halving 2024: Market Impact Predictions
April 14, 2024 Markets Rattle: Iran-Israel Conflict and Economic Data Ahead
Apple Should Climb The Wall Of Worry
Microsoft Q3 Preview: Focusing On Copilot
April 12, 2024 Improve Your Financial Status: A How-To Guide
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
March 6, 2024 Navigating GBP Forecast: Mistakes To Avoid In Forex Trading
Reata Pharmaceuticals (RETA) stock forecast for 2026
Updated: April 18, 2024 (06:52)
Sector: HealthcareThe share price of Reata Pharmaceuticals, Inc. (RETA) now
50/200 Day Moving Average: $ / $
This figure corresponds to the Average Price over the previous 50/200 days. For Reata Pharmaceuticals stocks, the 50-day moving average is the support level today.
For Reata Pharmaceuticals stocks, the 200-day moving average is the support level today.
Are you interested in Reata Pharmaceuticals, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Reata Pharmaceuticals stock price in 2026. How much will one Reata Pharmaceuticals share be worth in 2026? Is it worth taking profit / loss on RETA stock now or waiting? What are analysts' forecasts for Reata Pharmaceuticals stock?
We forecast Reata Pharmaceuticals stock performance using neural networks based on historical data on RETA stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.
Reata Pharmaceuticals, Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for Reata Pharmaceuticals analysts is $. Today 200 Day Moving Average is the support level ( $). 50 Day Moving Average is the support level ( $).
Historical and forecast chart of Reata Pharmaceuticals, Inc. stock
The chart below shows the historical price of Reata Pharmaceuticals stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the RETA stock price can be found in the table below.
Reata Pharmaceuticals, Inc., a clinical biopharmaceutical company, is developing new therapies for patients with serious or life-threatening illnesses by targeting molecular pathways that regulate cellular metabolism and inflammation.
Reata Pharmaceuticals (RETA) Forecast for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 184.38 | 168.15 | 198.76 | 15.40 % |
| Feb | 195.81 | 181.71 | 212.26 | 14.39 % |
| Mar | 157.04 | 141.96 | 169.92 | 16.45 % |
| Apr | 148.24 | 135.50 | 171.96 | 21.21 % |
| May | 158.03 | 148.55 | 179.84 | 17.40 % |
| Jun | 147.60 | 137.27 | 160.59 | 14.52 % |
| Jul | 173.87 | 152.66 | 196.82 | 22.44 % |
| Aug | 147.79 | 141.88 | 166.12 | 14.59 % |
| Sep | 157.25 | 139.01 | 179.89 | 22.73 % |
| Oct | 156.31 | 142.86 | 170.69 | 16.30 % |
| Nov | 169.75 | 160.58 | 188.08 | 14.62 % |
| Dec | 166.01 | 152.07 | 177.97 | 14.55 % |
Reata Pharmaceuticals information and performance
N/A
Market capitalization of the Reata Pharmaceuticals, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of RETA shares in the company outstanding by the market price of one share.
EBITDA of Reata Pharmaceuticals is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Reata Pharmaceuticals price target for 2026 by month
Target values for the price of one Reata Pharmaceuticals share for Jan 2026.
In Jan, the Positive dynamics for Reata Pharmaceuticals, Inc. shares will prevail with possible monthly volatility of 15.399% volatility is expected.
Pessimistic target level: 168.15
Optimistic target level: 198.76
Target values for the price of one Reata Pharmaceuticals share for Feb 2026.
In Feb, the Positive dynamics for Reata Pharmaceuticals, Inc. shares will prevail with possible monthly volatility of 14.391% volatility is expected.
Pessimistic target level: 181.71
Optimistic target level: 212.26
Target values for the price of one Reata Pharmaceuticals share for Mar 2026.
In Mar, the Negative dynamics for Reata Pharmaceuticals, Inc. shares will prevail with possible monthly volatility of 16.451% volatility is expected.
Pessimistic target level: 141.96
Optimistic target level: 169.92
Target values for the price of one Reata Pharmaceuticals share for Apr 2026.
In Apr, the Negative dynamics for Reata Pharmaceuticals, Inc. shares will prevail with possible monthly volatility of 21.207% volatility is expected.
Pessimistic target level: 135.50
Optimistic target level: 171.96
Target values for the price of one Reata Pharmaceuticals share for May 2026.
In May, the Positive dynamics for Reata Pharmaceuticals, Inc. shares will prevail with possible monthly volatility of 17.399% volatility is expected.
Pessimistic target level: 148.55
Optimistic target level: 179.84
Target values for the price of one Reata Pharmaceuticals share for Jun 2026.
In Jun, the Negative dynamics for Reata Pharmaceuticals, Inc. shares will prevail with possible monthly volatility of 14.522% volatility is expected.
Pessimistic target level: 137.27
Optimistic target level: 160.59
Target values for the price of one Reata Pharmaceuticals share for Jul 2026.
In Jul, the Positive dynamics for Reata Pharmaceuticals, Inc. shares will prevail with possible monthly volatility of 22.438% volatility is expected.
Pessimistic target level: 152.66
Optimistic target level: 196.82
Target values for the price of one Reata Pharmaceuticals share for Aug 2026.
In Aug, the Negative dynamics for Reata Pharmaceuticals, Inc. shares will prevail with possible monthly volatility of 14.591% volatility is expected.
Pessimistic target level: 141.88
Optimistic target level: 166.12
Target values for the price of one Reata Pharmaceuticals share for Sep 2026.
In Sep, the Positive dynamics for Reata Pharmaceuticals, Inc. shares will prevail with possible monthly volatility of 22.727% volatility is expected.
Pessimistic target level: 139.01
Optimistic target level: 179.89
Target values for the price of one Reata Pharmaceuticals share for Oct 2026.
In Oct, the Negative dynamics for Reata Pharmaceuticals, Inc. shares will prevail with possible monthly volatility of 16.301% volatility is expected.
Pessimistic target level: 142.86
Optimistic target level: 170.69
Target values for the price of one Reata Pharmaceuticals share for Nov 2026.
In Nov, the Positive dynamics for Reata Pharmaceuticals, Inc. shares will prevail with possible monthly volatility of 14.621% volatility is expected.
Pessimistic target level: 160.58
Optimistic target level: 188.08
Target values for the price of one Reata Pharmaceuticals share for Dec 2026.
In Dec, the Negative dynamics for Reata Pharmaceuticals, Inc. shares will prevail with possible monthly volatility of 14.553% volatility is expected.
Pessimistic target level: 152.07
Optimistic target level: 177.97
Related stocks from Healthcare sector
